Global clinical trial sample analysis organization GCCL announced on March 24 that it will participate in the 'World Vaccine Congress 2026 (WVC ...
Patients with non-Hodgkin lymphoma including chronic lymphocytic leukemia (NHL/CLL) are at higher risk of severe SARS-CoV-2 infection. We investigated vaccine-induced antibody responses in patients ...
GCCL Co., Ltd. (GCCL), a global clinical trial laboratory services provider, announced that it will attend World Vaccine Congress 2026 (WVC 2026), taking place from March 30 to April 2 in Washington, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results